Market Place
Sourcing Support
FDA Review Update on VTAMA® (Tapinarof) for Atopic Dermatitis
05 Nov 2024 //
BUSINESSWIRE
GE HealthCare reports third quarter 2024 financial results
30 Oct 2024 //
BUSINESSWIRE
Organon Acquires Dermavant, Including VTAMA® (tapinarof) Cream
28 Oct 2024 //
#N/A
Organon Acquires Dermavant, Including VTAMA® Cream
28 Oct 2024 //
BUSINESSWIRE
Organon To Report Q3 2024 Results October 31
09 Oct 2024 //
BUSINESSWIRE
Primary Endpoint Met In Ph 3 Study Of Perjeta Biosimilar HLX11
30 Sep 2024 //
PRESS RELEASE
Organon pays up to $1.2B to acquire Dermavant and its steroid-free cream Vtama
19 Sep 2024 //
REUTERS
Organon pays $22.5M to expand Emgality marketing pact with Lilly
20 Aug 2024 //
FIERCE PHARMA
Organon And Lilly Expand Migraine Commercialization To 11 More Markets
20 Aug 2024 //
BUSINESSWIRE
Organon Reports Results for the Second Quarter Ended June 30, 2024
06 Aug 2024 //
BUSINESSWIRE
Organon To Report Q2 2024 Results On August 6
09 Jul 2024 //
BUSINESSWIRE
Enforcement Report - Week of June 19, 2024
19 Jun 2024 //
FDA
Organon Announces Proposed $1.0 Billion Senior Notes Offering
07 May 2024 //
BUSINESSWIRE
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
07 May 2024 //
BUSINESSWIRE
Organon Reports Results for the First Quarter Ended March 31, 2024
02 May 2024 //
BUSINESSWIRE
Phase 3 Comparative Clinical Study of Prolia® and Xgeva Met Primary Endpoints
08 Apr 2024 //
BUSINESSWIRE
Organon To Report First Quarter 2024 Results and Host Conference Call
08 Apr 2024 //
BUSINESSWIRE
New York attorney general urges stronger safety warning on asthma drug Singulair
23 Feb 2024 //
REUTERS
Organon Launches Programs and Listening Tour as Part of "Her Plan Is Her Power"
20 Feb 2024 //
ACCESSWIRE
Organon Announces HADLIMA Has Been Selected by the US Department of VA
20 Feb 2024 //
BUSINESSWIRE
Organon`s Humira biosimilar gets exclusive spot on VA formulary
16 Feb 2024 //
ENDPTS
Organon Co earnings beat by $0.09, revenue topped estimates
15 Feb 2024 //
PRESS RELEASE
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31
15 Feb 2024 //
BUSINESSWIRE
Organon shelves contraceptive with `natural` estrogen
13 Feb 2024 //
ENDPTS
Organon`s Biologic Follistim AQ (follitropin) Receives Approval in the U.S.
07 Feb 2024 //
FDA
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call
01 Feb 2024 //
BUSINESSWIRE
Organon’s XACIATO Vaginal Gel 2% Available Nationwide to Treat BV
10 Jan 2024 //
BUSINESSWIRE
Organon affirms 2023 revenue
08 Jan 2024 //
BUSINESSWIRE
Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference
21 Dec 2023 //
BUSINESSWIRE
Organon is taking over marketing of two Lilly meds in Europe
18 Dec 2023 //
FIERCE PHARMA
Organon To Present at the Piper Sandler 35th Annual Healthcare Conference
21 Nov 2023 //
BUSINESSWIRE
Organon to work with White House on women`s health research: CEO
15 Nov 2023 //
FIERCE BIOTECH
Samsung Bioepis & Organon Announce Acceptance of sBLA for Interchangeability Designation for HADLIMA
07 Nov 2023 //
GLOBENEWSWIRE
Organon Reports Results for the Third Quarter Ended September 30, 2023
02 Nov 2023 //
BUSINESSWIRE
Organon and Sempre Health Announce Collaboration
01 Nov 2023 //
BUSINESSWIRE
Organon Returns Ebopiprant to XOMA
27 Oct 2023 //
GLOBENEWSWIRE
Organon To Report Third Quarter Results and Host Conference on November 2, 2023
19 Oct 2023 //
BUSINESSWIRE
Organon Recognized on Fortune’s 2023 Change the World List
27 Sep 2023 //
BUSINESSWIRE
Organon touts real-world win of its postpartum hemorrhage device
18 Sep 2023 //
FIERCE BIOTECH
Organon Bolsters R&D Expertise with Two Leadership Appointments
05 Sep 2023 //
BUSINESSWIRE
Organon Reports Results for the Second Quarter Ended June 30, 2023
08 Aug 2023 //
BUSINESSWIRE
Samsung Bioepis & Organon Announce Results from Study of SB5 Humira Biosimilar
01 Aug 2023 //
GLOBENEWSWIRE
Organon To Report Second Quarter Results and Host Conference on August 8, 2023
17 Jul 2023 //
BUSINESSWIRE
Organon, Samsung launch copycat for arthritis drug Humira at 85% discount
03 Jul 2023 //
REUTERS
Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA
01 Jul 2023 //
BUSINESSWIRE
Organon allies with Latin American bank to boost women`s health
14 Jun 2023 //
FIERCE PHARMA
Organon and CAF Launch First-of-Its-Kind Collaboration
07 Jun 2023 //
BUSINESSWIRE
Organon builds pipeline for women`s health but can`t do it alone
16 Mar 2023 //
FIERCE BIOTECH
Organon pledges $30M to improve contraceptive info
09 Mar 2023 //
FIERCE PHARMA
Organon doubles down on mission to prevent unplanned pregnancies
08 Mar 2023 //
ENDPTS
Organon Launches “Her Plan is Her Power”
07 Mar 2023 //
BUSINESSWIRE
Organon Reports Results for Fourth Quarter and Full Year Ended December 31, 2022
16 Feb 2023 //
BUSINESSWIRE
Organon To Report Fourth Quarter and Full Year Results
06 Feb 2023 //
BUSINESSWIRE
Organon places bet on hysterectomy hardware maker Claria Medical
09 Jan 2023 //
FIERCE BIOTECH
Organon Makes Strategic Investment in Claria Medical to Support Development
05 Jan 2023 //
BIOSPACE
Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference
15 Dec 2022 //
BUSINESSWIRE
Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
12 Dec 2022 //
BUSINESSWIRE
Organon joins global push to prevent unintended pregnancies
29 Nov 2022 //
FIERCEPHARMA
Organon To Present at the Piper Sandler 34th Annual Healthcare Conference
15 Nov 2022 //
BUSINESSWIRE
Organon To Report Third Quarter Results and Host Conference Call
20 Oct 2022 //
BUSINESSWIRE
